At-home Monitoring of patients during Chemoradiation for Oesophageal canceR: the AMCOR trial
Not yet recruiting
- Conditions
- oesophageal cancer10027656
- Registration Number
- NL-OMON53606
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1. Age >= 18 at the time of signing informed consent.
2. Histologically proven adenocarcinoma, squamous cell carcinoma or mixed type
of the oesophagus or gastro-oesophageal junction.
3. Indication for definitive or neoadjuvant CRT, with chemotherapy that
consists of weekly carboplatin/paclitaxel.
4. Written, informed consent.
5. Ability to comply with all protocol required actions (at home measurements
are done individually by the participant him- or herself).
Exclusion Criteria
1. Altered mental status, or any psychiatric condition that would prohibit the
understanding or rendering of informed consent or the carrying out of the
measurements at home.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>At least 80% of participants complete at least 80% of predefined at home<br /><br>measurements.</p><br>
- Secondary Outcome Measures
Name Time Method <p>n.a.</p><br>